Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.

[1]  Himadri S. Gupta,et al.  Structure and mechanical quality of the collagen–mineral nano-composite in bone , 2004 .

[2]  P. Kostenuik,et al.  Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. , 2004, Bone.

[3]  M. Bouxsein,et al.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis , 2004 .

[4]  P. Fratzl,et al.  Cellular Solids beyond the Apparent Density – an Experimental Assessment of Mechanical Properties , 2004 .

[5]  H. Bergmeister,et al.  Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. , 2004, The American journal of pathology.

[6]  R. Nissenson,et al.  PTH Differentially Regulates Expression of RANKL and OPG , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  J. Finkelstein,et al.  The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. , 2003, The New England journal of medicine.

[8]  Steven W. Martin,et al.  Sustained Antiresorptive Effects After a Single Treatment With Human Recombinant Osteoprotegerin (OPG): A Pharmacodynamic and Pharmacokinetic Analysis in Rats , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  P. Fratzl,et al.  Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. , 2003, The Journal of clinical endocrinology and metabolism.

[10]  P. Fratzl,et al.  Orientation of Mineral Crystallites and Mineral Density During Skeletal Development in Mice Deficient in Tissue Nonspecific Alkaline Phosphatase , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  S. Khosla,et al.  Minireview: the OPG/RANKL/RANK system. , 2001, Endocrinology.

[12]  P. Kostenuik,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society OPG and PTH-(1–34) Have Additive Effects on Bone Density and Mechanical Strength in Osteopenic Ovariectomized Rats , 2022 .

[13]  R Müller,et al.  Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study * , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  P. Fratzl,et al.  Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. , 2001, Bone.

[15]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[16]  P. Kostenuik,et al.  Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. , 2001, Current pharmaceutical design.

[17]  R. Recker,et al.  Maintenance of vertebral body bone mass and strength created by human parathyroid hormone treatment in ovariectomized rats. , 2001, Bone.

[18]  R. Recker,et al.  Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats. , 2001, Bone.

[19]  A. Boyde,et al.  Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). , 2001, Bone.

[20]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[21]  F. Lopez,et al.  New approaches to the treatment of osteoporosis. , 2000, Current opinion in chemical biology.

[22]  P. Fratzl,et al.  Analysis of the hierarchical structure of biological tissues by scanning X-ray scattering using a micro-beam. , 2000, Cellular and molecular biology.

[23]  D L Lacey,et al.  RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Roberson,et al.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. , 1999, The Journal of clinical investigation.

[25]  P. Fratzl,et al.  Scanning Small Angle X-ray Scattering Analysis of Human Bone Sections , 1999, Calcified Tissue International.

[26]  S. Morony,et al.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.

[27]  P. Fratzl,et al.  Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. , 1998, Bone.

[28]  R. Turner,et al.  Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats. , 1998, Endocrinology.

[29]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[30]  R. Turner,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society The Effects of Programmed Administration of Human Parathyroid Hormone Fragment (1–34) on Bone Histomorphometry and Serum Chemistry in Rats* , 2022 .

[31]  P. Fratzl,et al.  Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs. , 1997, Bone.

[32]  K. Bachus,et al.  Determining mineral content variations in bone using backscattered electron imaging. , 1997, Bone.

[33]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[34]  P. Fratzl,et al.  Effects of sodium fluoride and alendronate on the bone mineral in minipigs: A small‐angle X‐ray scattering and backscattered electron imaging study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[36]  P. Delmas,et al.  The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? , 1995, Bone.

[37]  W. Landis.  The strength of a calcified tissue depends in part on the molecular structure and organization of its constituent mineral crystals in their organic matrix. , 1995, Bone.

[38]  H. Plenk,et al.  A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities. , 1995, Scanning microscopy.

[39]  P. Fratzl,et al.  Abnormal bone mineralization after fluoride treatment in osteoporosis: A small‐angle x‐ray‐scattering study , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  A. Hodsman,et al.  Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces. , 1992, Bone.

[41]  P. Fratzl,et al.  Mineral crystals in calcified tissues: A comparative study by SAXS , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  J Reeve,et al.  Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. , 1980, British medical journal.

[43]  P. Fratzl,et al.  Bone mineralization as studied by small-angle x-ray scattering. , 1996, Connective tissue research.

[44]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[45]  M. Ashby,et al.  Cellular solids: Structure & properties , 1988 .

[46]  A. Boyde,et al.  Scanning electron microscopy in bone pathology: review of methods, potential and applications. , 1986, Scanning electron microscopy.

[47]  J M Hock,et al.  Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. , 1984, Metabolic bone disease & related research.